Stoke Therapeutics Inc buy Chardan Capital
Start price
13.08.25
/
50%
€13.80
Target price
13.08.26
€20.55
Performance (%)
78.26%
Price
26.01.26
€24.60
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital for Stoke Therapeutics Inc has seen massive gains of 78.26%. This prediction currently runs until 13.08.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 1.653% | 1.653% |
| iShares Core DAX® | -0.121% | 2.507% |
| iShares Nasdaq 100 | 0.081% | -0.241% |
| iShares Nikkei 225® | -1.748% | 4.105% |
| iShares S&P 500 | -0.961% | -0.143% |
Comments by Chardan_Capital for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€25.80
05.01.26
05.01.26
€29.93
05.01.27
05.01.27
-4.65%
26.01.26
26.01.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.95
19.02.25
19.02.25
€23.00
19.02.26
19.02.26
174.86%
26.01.26
26.01.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€10.70
20.12.24
20.12.24
€23.06
20.12.25
20.12.25
152.34%
21.12.25
21.12.25